Table 3. Comparison of quality of life between two groups (Q2(Q1-Q3)).
Variable | Before the intervention | 1 month after discharge | 6 months after discharge | ||||||
---|---|---|---|---|---|---|---|---|---|
Intervention group (n = 70) | Control group (n = 70) |
P Value |
Intervention group (n = 70) | Control group (n = 70) | P Value | Intervention group (n = 70) | Control group (n = 70) |
P Value | |
Symptoms | 17.86(12.50–26.79) | 15.46(10.41–20.52) | 0.081 | 100.00(82.13–100.0) | 83.01(73.21–100.0) | 0.093 | 100.00(100.0–100.0) | 100.00(81.97–100.0) | 0.002** |
Physical function | 21.88(0.0–31.25) | 15.63(4.69–25.00) | 0.250 | 93.75(87.5–100.0) | 93.75(87.50–93.75) | 0.012* | 100.00(93.75–100.0) | 93.75(93.75–100.0) | 0.004** |
Psychosocial function | 25.00(3.57–35.71) | 17.86(8.93–44.64) | 0.972 | 54.46(46.43–60.71) | 37.50(32.14–46.42) | 0.000** | 75.00(62.50–85.71) | 60.71(50.0–75.0) | 0.007** |
Cognitive function | 60.00(40.0–73.33) | 60.00(40.0–60.0) | 0.078 | 73.33(60.0–86.67) | 60.00(60.00–60.00) | 0.000** | 80.00(60.0–100.0) | 80.00(60.0–80.0) | 0.025* |
Adverse reactions | 45.83(37.5–50.00) | 41.67(25.0–58.33) | 0.737 | 100.00(100.0–100.0) | 100.00(100–100) | 0.500 | 100.00(95.83–100.0) | 100.00(100.0–100.0) | 0.018* |
Treatment satisfaction | 51.39(47.22–56.94) | 51.39(51.39–54.51) | 0.281 | 83.33(66.67–100.0) | 62.50(55.20–62.50) | 0.000** | 100.00(95.83–100.0) | 66.67(62.50–92.71) | 0.000** |
Total score | 211.51(182.45–248.87) | 201.51(173.63–229.52) | 0.067 | 484.81±52.91 | 432.49±34.99 | 0.000** | 544.29(5509.99–568.04) | 494.33(455.97–530.15) | 0.000** |
* P<0.05
**P<0.01